MSC Cruises has announced its restart plans for cruising from U.S. ports beginning in August aboard MSC Meraviglia and MSC Divina.
The announcement follows approval by the U.S. Centers for Disease Control and Prevention (CDC) for the cruise line’s Phase 2A Port Agreements for PortMiami and Port Canaveral, as well as the provisional approval of its request to conduct a simulation cruise, to be held on MSC Meraviglia from PortMiami on July 17, 2021.
The new MSC Cruises itineraries will be open for booking from June 16, 2021. MSC Meraviglia will sail 3- and 4-night cruises from Miami to The Bahamas starting Aug. 2, 2021, including a call at MSC Cruises’ new private island destination, Ocean Cay MSC Marine Reserve. MSC Meraviglia will then add 7-night cruises from Miami to The Bahamas and Caribbean. MSC Divina will resume cruising from Orlando (Port Canaveral) on Sept. 16, 2021, offering 3-, 4- and 7-night itineraries to The Bahamas and Caribbean.
“After what has been a challenging period, we’re thrilled to say it’s finally time to cruise again,” said Gianni Onorato, CEO, MSC Cruises, in a press release statement. “We are excited to be officially announcing our restart this summer from the U.S., and Florida in particular, as excitement is building for vacationers to get back to traveling and plan a much-deserved getaway.”
The cruise line has also confirmed the cancellation of existing sailings from U.S. ports. Cruises impacted include MSC Divina sailings from Port Canaveral between July 1, 2021 and Sept. 15, 2021; MSC Meraviglia sailings from PortMiami between July 1, 2021 and Sept. 17, 2021; and MSC Armonia sailings from PortMiami between July 1, 2021 and Oct. 24, 2021.
Guests booked on the impacted sailings — and who have paid in full and booked through MSC Cruises USA or affiliated U.S.-based travel advisors — will be offered a 100 percent future cruise credit (FCC) of the original cruise fare and up to $200 onboard credit, depending on the length of the original cruise.
For more information, visit msccruisesusa.com.